Global Antisense and RNAi Therapeutics Market Size, Status and Forecast 2020-2026

Global Antisense and RNAi Therapeutics Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Market Analysis by Type
1.3.1 Global Antisense and RNAi Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.3.2 RNA Interference
1.3.3 Antisense RNA
1.4 Market by Application
1.4.1 Global Antisense and RNAi Therapeutics Market Share by Application: 2020 VS 2026
1.4.2 Hospital
1.4.3 Clinic
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antisense and RNAi Therapeutics Market Perspective (2015-2026)
2.2 Antisense and RNAi Therapeutics Growth Trends by Regions
2.2.1 Antisense and RNAi Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Antisense and RNAi Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Antisense and RNAi Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Antisense and RNAi Therapeutics Industry Dynamic
2.3.1 Antisense and RNAi Therapeutics Market Trends
2.3.2 Antisense and RNAi Therapeutics Market Drivers
2.3.3 Antisense and RNAi Therapeutics Market Challenges
2.3.4 Antisense and RNAi Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antisense and RNAi Therapeutics Players by Market Size
3.1.1 Global Top Antisense and RNAi Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Antisense and RNAi Therapeutics Revenue Market Share by Players (2015-2020)
3.2 Global Antisense and RNAi Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Antisense and RNAi Therapeutics Revenue
3.4 Global Antisense and RNAi Therapeutics Market Concentration Ratio
3.4.1 Global Antisense and RNAi Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antisense and RNAi Therapeutics Revenue in 2019
3.5 Key Players Antisense and RNAi Therapeutics Area Served
3.6 Key Players Antisense and RNAi Therapeutics Product Solution and Service
3.7 Date of Enter into Antisense and RNAi Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Antisense and RNAi Therapeutics Breakdown Data by Type
4.1 Global Antisense and RNAi Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Antisense and RNAi Therapeutics Forecasted Market Size by Type (2021-2026)
5 Antisense and RNAi Therapeutics Breakdown Data by Application
5.1 Global Antisense and RNAi Therapeutics Historic Market Size by Application (2015-2020)
5.2 Global Antisense and RNAi Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Antisense and RNAi Therapeutics Market Size (2015-2026)
6.2 North America Antisense and RNAi Therapeutics Market Size by Type (2015-2020)
6.3 North America Antisense and RNAi Therapeutics Market Size by Application (2015-2020)
6.4 North America Antisense and RNAi Therapeutics Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Antisense and RNAi Therapeutics Market Size (2015-2026)
7.2 Europe Antisense and RNAi Therapeutics Market Size by Type (2015-2020)
7.3 Europe Antisense and RNAi Therapeutics Market Size by Application (2015-2020)
7.4 Europe Antisense and RNAi Therapeutics Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Antisense and RNAi Therapeutics Market Size (2015-2026)
8.2 Asia-Pacific Antisense and RNAi Therapeutics Market Size by Type (2015-2020)
8.3 Asia-Pacific Antisense and RNAi Therapeutics Market Size by Application (2015-2020)
8.4 Asia-Pacific Antisense and RNAi Therapeutics Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
9 Latin America
9.1 Latin America Antisense and RNAi Therapeutics Market Size (2015-2026)
9.2 Latin America Antisense and RNAi Therapeutics Market Size by Type (2015-2020)
9.3 Latin America Antisense and RNAi Therapeutics Market Size by Application (2015-2020)
9.4 Latin America Antisense and RNAi Therapeutics Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antisense and RNAi Therapeutics Market Size (2015-2026)
10.2 Middle East & Africa Antisense and RNAi Therapeutics Market Size by Type (2015-2020)
10.3 Middle East & Africa Antisense and RNAi Therapeutics Market Size by Application (2015-2020)
10.4 Middle East & Africa Antisense and RNAi Therapeutics Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11Key Players Profiles
11.1 Tekmira Pharmaceuticals
11.1.1 Tekmira Pharmaceuticals Company Details
11.1.2 Tekmira Pharmaceuticals Business Overview
11.1.3 Tekmira Pharmaceuticals Antisense and RNAi Therapeutics Introduction
11.1.4 Tekmira Pharmaceuticals Revenue in Antisense and RNAi Therapeutics Business (2015-2020))
11.1.5 Tekmira Pharmaceuticals Recent Development
11.2 Arbutus Biopharma
11.2.1 Arbutus Biopharma Company Details
11.2.2 Arbutus Biopharma Business Overview
11.2.3 Arbutus Biopharma Antisense and RNAi Therapeutics Introduction
11.2.4 Arbutus Biopharma Revenue in Antisense and RNAi Therapeutics Business (2015-2020)
11.2.5 Arbutus Biopharma Recent Development
11.3 Alnylam Pharmaceuticals
11.3.1 Alnylam Pharmaceuticals Company Details
11.3.2 Alnylam Pharmaceuticals Business Overview
11.3.3 Alnylam Pharmaceuticals Antisense and RNAi Therapeutics Introduction
11.3.4 Alnylam Pharmaceuticals Revenue in Antisense and RNAi Therapeutics Business (2015-2020)
11.3.5 Alnylam Pharmaceuticals Recent Development
11.4 Antisense Therapeutics
11.4.1 Antisense Therapeutics Company Details
11.4.2 Antisense Therapeutics Business Overview
11.4.3 Antisense Therapeutics Antisense and RNAi Therapeutics Introduction
11.4.4 Antisense Therapeutics Revenue in Antisense and RNAi Therapeutics Business (2015-2020)
11.4.5 Antisense Therapeutics Recent Development
11.5 Silence Therapeutics
11.5.1 Silence Therapeutics Company Details
11.5.2 Silence Therapeutics Business Overview
11.5.3 Silence Therapeutics Antisense and RNAi Therapeutics Introduction
11.5.4 Silence Therapeutics Revenue in Antisense and RNAi Therapeutics Business (2015-2020)
11.5.5 Silence Therapeutics Recent Development
11.6 Isis Pharmaceuticals
11.6.1 Isis Pharmaceuticals Company Details
11.6.2 Isis Pharmaceuticals Business Overview
11.6.3 Isis Pharmaceuticals Antisense and RNAi Therapeutics Introduction
11.6.4 Isis Pharmaceuticals Revenue in Antisense and RNAi Therapeutics Business (2015-2020)
11.6.5 Isis Pharmaceuticals Recent Development
11.7 Sirnaomics
11.7.1 Sirnaomics Company Details
11.7.2 Sirnaomics Business Overview
11.7.3 Sirnaomics Antisense and RNAi Therapeutics Introduction
11.7.4 Sirnaomics Revenue in Antisense and RNAi Therapeutics Business (2015-2020)
11.7.5 Sirnaomics Recent Development
11.8 Santaris
11.8.1 Santaris Company Details
11.8.2 Santaris Business Overview
11.8.3 Santaris Antisense and RNAi Therapeutics Introduction
11.8.4 Santaris Revenue in Antisense and RNAi Therapeutics Business (2015-2020)
11.8.5 Santaris Recent Development
11.9 Roche
11.9.1 Roche Company Details
11.9.2 Roche Business Overview
11.9.3 Roche Antisense and RNAi Therapeutics Introduction
11.9.4 Roche Revenue in Antisense and RNAi Therapeutics Business (2015-2020)
11.9.5 Roche Recent Development
12Analyst's Viewpoints/Conclusions
13Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Antisense and RNAi Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 2. Key Players of RNA Interference
Table 3. Key Players of Antisense RNA
Table 4. Global Antisense and RNAi Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 5. Global Antisense and RNAi Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 6. Global Antisense and RNAi Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 7. Global Antisense and RNAi Therapeutics Market Share by Regions (2015-2020)
Table 8. Global Antisense and RNAi Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 9. Global Antisense and RNAi Therapeutics Market Share by Regions (2021-2026)
Table 10. Antisense and RNAi Therapeutics Market Market Trends
Table 11. Antisense and RNAi Therapeutics Market Drivers
Table 12. Antisense and RNAi Therapeutics Market Challenges
Table 13. Antisense and RNAi Therapeutics Market Restraints
Table 14. Global Antisense and RNAi Therapeutics Revenue by Players (2015-2020) (US$ Million)
Table 15. Global Antisense and RNAi Therapeutics Market Share by Players (2015-2020)
Table 16. Global Top Antisense and RNAi Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antisense and RNAi Therapeutics as of 2019)
Table 17. Global Antisense and RNAi Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 18. Key Players Headquarters and Area Served
Table 19. Key Players Antisense and RNAi Therapeutics Product Solution and Service
Table 20. Mergers & Acquisitions, Expansion Plans
Table 21. Global Antisense and RNAi Therapeutics Market Size by Type (2015-2020) (US$ Million)
Table 22. Global Antisense and RNAi Therapeutics Revenue Market Share by Type (2015-2020)
Table 23. Global Antisense and RNAi Therapeutics Forecasted Market Size by Type (2021-2026) (US$ Million)
Table 24. Global Antisense and RNAi Therapeutics Market Size Share by Application (2015-2020) (US$ Million)
Table 25. Global Antisense and RNAi Therapeutics Revenue Market Share by Application (2015-2020)
Table 26. Global Antisense and RNAi Therapeutics Forecasted Market Size by Application (2021-2026) (US$ Million)
Table 27. North America Antisense and RNAi Therapeutics Market Size by Type (2015-2020) (US$ Million)
Table 28. North America Antisense and RNAi Therapeutics Market Share by Type (2015-2020)
Table 29. North America Antisense and RNAi Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 30. North America Antisense and RNAi Therapeutics Market Share by Application (2015-2020)
Table 31. North America Antisense and RNAi Therapeutics Market Size by Country (US$ Million) (2015-2020)
Table 32. North America Antisense and RNAi Therapeutics Market Share by Country (2015-2020)
Table 33. Europe Antisense and RNAi Therapeutics Market Size by Type (2015-2020) (US$ Million)
Table 34. Europe Antisense and RNAi Therapeutics Market Share by Type (2015-2020)
Table 35. Europe Antisense and RNAi Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 36. Europe Antisense and RNAi Therapeutics Market Share by Application (2015-2020)
Table 37. Europe Antisense and RNAi Therapeutics Market Size by Country (US$ Million) (2015-2020)
Table 38. Europe Antisense and RNAi Therapeutics Market Share by Country (2015-2020)
Table 39. Asia-Pacific Antisense and RNAi Therapeutics Market Size by Type (2015-2020) (US$ Million)
Table 40. Asia-Pacific Antisense and RNAi Therapeutics Market Share by Type (2015-2020)
Table 41. Asia-Pacific Antisense and RNAi Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 42. Asia-Pacific Antisense and RNAi Therapeutics Market Share by Application (2015-2020)
Table 43. Asia-Pacific Antisense and RNAi Therapeutics Market Size by Region (US$ Million) (2015-2020)
Table 44. Asia-Pacific Antisense and RNAi Therapeutics Market Share by Region (2015-2020)
Table 45. Latin America Antisense and RNAi Therapeutics Market Size by Type (2015-2020) (US$ Million)
Table 46. Latin America Antisense and RNAi Therapeutics Market Share by Type (2015-2020)
Table 47. Latin America Antisense and RNAi Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 48. Latin America Antisense and RNAi Therapeutics Market Share by Application (2015-2020)
Table 49. Latin America Antisense and RNAi Therapeutics Market Size by Country (US$ Million) (2015-2020)
Table 50. Latin America Antisense and RNAi Therapeutics Market Share by Country (2015-2020)
Table 51. Middle East & Africa Antisense and RNAi Therapeutics Market Size by Type (2015-2020) (US$ Million)
Table 52. Middle East & Africa Antisense and RNAi Therapeutics Market Share by Type (2015-2020)
Table 53. Middle East & Africa Antisense and RNAi Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 54. Middle East & Africa Antisense and RNAi Therapeutics Market Share by Application (2015-2020)
Table 55. Middle East & Africa Antisense and RNAi Therapeutics Market Size by Country (US$ Million) (2015-2020)
Table 56. Middle East & Africa Antisense and RNAi Therapeutics Market Share by Country (2015-2020)
Table 57. Tekmira Pharmaceuticals Company Details
Table 58. Tekmira Pharmaceuticals Business Overview
Table 59. Tekmira Pharmaceuticals Antisense and RNAi Therapeutics Product
Table 60. Tekmira Pharmaceuticals Revenue in Antisense and RNAi Therapeutics Business (2015-2020) (US$ Million)
Table 61. Tekmira Pharmaceuticals Recent Development
Table 62. Arbutus Biopharma Company Details
Table 63. Arbutus Biopharma Business Overview
Table 64. Arbutus Biopharma Antisense and RNAi Therapeutics Product
Table 65. Arbutus Biopharma Revenue in Antisense and RNAi Therapeutics Business (2015-2020) (US$ Million)
Table 66. Arbutus Biopharma Recent Development
Table 67. Alnylam Pharmaceuticals Company Details
Table 68. Alnylam Pharmaceuticals Business Overview
Table 69. Alnylam Pharmaceuticals Antisense and RNAi Therapeutics Product
Table 70. Alnylam Pharmaceuticals Revenue in Antisense and RNAi Therapeutics Business (2015-2020) (US$ Million)
Table 71. Alnylam Pharmaceuticals Recent Development
Table 72. Antisense Therapeutics Company Details
Table 73. Antisense Therapeutics Business Overview
Table 74. Antisense Therapeutics Antisense and RNAi Therapeutics Product
Table 75. Antisense Therapeutics Revenue in Antisense and RNAi Therapeutics Business (2015-2020) (US$ Million)
Table 76. Antisense Therapeutics Recent Development
Table 77. Silence Therapeutics Company Details
Table 78. Silence Therapeutics Business Overview
Table 79. Silence Therapeutics Antisense and RNAi Therapeutics Product
Table 80. Silence Therapeutics Revenue in Antisense and RNAi Therapeutics Business (2015-2020) (US$ Million)
Table 81. Silence Therapeutics Recent Development
Table 82. Isis Pharmaceuticals Company Details
Table 83. Isis Pharmaceuticals Business Overview
Table 84. Isis Pharmaceuticals Antisense and RNAi Therapeutics Product
Table 85. Isis Pharmaceuticals Revenue in Antisense and RNAi Therapeutics Business (2015-2020) (US$ Million)
Table 86. Isis Pharmaceuticals Recent Development
Table 87. Sirnaomics Company Details
Table 88. Sirnaomics Business Overview
Table 89. Sirnaomics Antisense and RNAi Therapeutics Product
Table 90. Sirnaomics Revenue in Antisense and RNAi Therapeutics Business (2015-2020) (US$ Million)
Table 91. Sirnaomics Recent Development
Table 92. Santaris Business Overview
Table 93. Santaris Antisense and RNAi Therapeutics Product
Table 94. Santaris Company Details
Table 95. Santaris Revenue in Antisense and RNAi Therapeutics Business (2015-2020) (US$ Million)
Table 96. Santaris Recent Development
Table 97. Roche Company Details
Table 98. Roche Business Overview
Table 99. Roche Antisense and RNAi Therapeutics Product
Table 100. Roche Revenue in Antisense and RNAi Therapeutics Business (2015-2020) (US$ Million)
Table 101. Roche Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Antisense and RNAi Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. RNA Interference Features
Figure 3. Antisense RNA Features
Figure 4. Global Antisense and RNAi Therapeutics Market Share by Application: 2020 VS 2026
Figure 5. Hospital Case Studies
Figure 6. Clinic Case Studies
Figure 7. Antisense and RNAi Therapeutics Report Years Considered
Figure 8. Global Antisense and RNAi Therapeutics Market Size (US$ Million), YoY Growth 2015-2026
Figure 9. Global Antisense and RNAi Therapeutics Market Share by Regions: 2020 VS 2026
Figure 10. Global Antisense and RNAi Therapeutics Market Share by Regions (2021-2026)
Figure 11. Global Antisense and RNAi Therapeutics Market Share by Players in 2019
Figure 12. Global Top Antisense and RNAi Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antisense and RNAi Therapeutics as of 2019
Figure 13. The Top 10 and 5 Players Market Share by Antisense and RNAi Therapeutics Revenue in 2019
Figure 14. North America Antisense and RNAi Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 15. United States Antisense and RNAi Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 16. Canada Antisense and RNAi Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 17. Europe Antisense and RNAi Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 18. Germany Antisense and RNAi Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. France Antisense and RNAi Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. U.K. Antisense and RNAi Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. Italy Antisense and RNAi Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. Russia Antisense and RNAi Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. Nordic Antisense and RNAi Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Asia-Pacific Antisense and RNAi Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. China Antisense and RNAi Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Japan Antisense and RNAi Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. South Korea Antisense and RNAi Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Southeast Asia Antisense and RNAi Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. India Antisense and RNAi Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. Australia Antisense and RNAi Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. Rest of Asia-Pacific Antisense and RNAi Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. Latin America Antisense and RNAi Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Mexico Antisense and RNAi Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Brazil Antisense and RNAi Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Middle East & Africa Antisense and RNAi Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Turkey Antisense and RNAi Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Saudi Arabia Antisense and RNAi Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. UAE Antisense and RNAi Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Tekmira Pharmaceuticals Revenue Growth Rate in Antisense and RNAi Therapeutics Business (2015-2020)
Figure 40. Arbutus Biopharma Revenue Growth Rate in Antisense and RNAi Therapeutics Business (2015-2020)
Figure 41. Alnylam Pharmaceuticals Revenue Growth Rate in Antisense and RNAi Therapeutics Business (2015-2020)
Figure 42. Antisense Therapeutics Revenue Growth Rate in Antisense and RNAi Therapeutics Business (2015-2020)
Figure 43. Silence Therapeutics Revenue Growth Rate in Antisense and RNAi Therapeutics Business (2015-2020)
Figure 44. Isis Pharmaceuticals Revenue Growth Rate in Antisense and RNAi Therapeutics Business (2015-2020)
Figure 45. Sirnaomics Revenue Growth Rate in Antisense and RNAi Therapeutics Business (2015-2020)
Figure 46. Santaris Revenue Growth Rate in Antisense and RNAi Therapeutics Business (2015-2020)
Figure 47. Roche Revenue Growth Rate in Antisense and RNAi Therapeutics Business (2015-2020)
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Targeted RNA Sequencing Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 71

Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest and offers both quantitative and qualitative information. Targeted RNA-Seq can be achieved via either enrichment or amplicon-based approaches, both of which enable gene expression analysis in a focused set of genes of interest, with enrichment assays also providing The ability to detect both known and novel gene fusion partners in many sample types. In The report, we ......

Global Targeted RNA Sequencing Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 87

According to our LPI (LP Information) latest study, the global Targeted RNA Sequencing market size was valued at US$ 1761.4 million in 2023. With growing demand in downstream market, the Targeted RNA Sequencing is forecast to a readjusted size of US$ 7649.2 million by 2030 with a CAGR of 23.3% during review period. The research report highlights the growth potential of the global Targeted RNA Sequencing market. Targeted RNA Sequencing are expected to show stable growth in the future mark......

Global Targeted RNA Sequencing Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 94

According to our (Global Info Research) latest study, the global Targeted RNA Sequencing market size was valued at USD 1852.7 million in 2023 and is forecast to a readjusted size of USD 7255.4 million by 2030 with a CAGR of 21.5% during review period. Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest and offers both quantitative and qualitative information. Targeted RNA-Seq can be achieved via either enrichment or ......

Global Antisense and RNAi Therapeutics Market Research Report 2023, Forecast to 2028

Published: 26-Dec-2023        Price: US 2680 Onwards        Pages: 133

Antisense therapy means the selective, sequence-specific inhibition of gene expression by single-stranded DNA oligonucleotides. In contrast, RNA interference (RNAi) is triggered by double-stranded RNA (dsRNA) and causes sequence-specific mRNA degradation of single-stranded target RNAs in response to dsRNA. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (millio......

Global Antisense and RNAi Therapeutics Professional Survey Report 2023, Forecast to 2028

Published: 26-Dec-2023        Price: US 3280 Onwards        Pages: 101

Antisense therapy means the selective, sequence-specific inhibition of gene expression by single-stranded DNA oligonucleotides. In contrast, RNA interference (RNAi) is triggered by double-stranded RNA (dsRNA) and causes sequence-specific mRNA degradation of single-stranded target RNAs in response to dsRNA. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (millio......

Global Targeted RNA Sequencing Market Research Report 2023, Forecast to 2028

Published: 13-Nov-2023        Price: US 2680 Onwards        Pages: 137

Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest.  Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product ......

Global Targeted RNA Sequencing Professional Survey Report 2023, Forecast to 2028

Published: 13-Nov-2023        Price: US 3280 Onwards        Pages: 100

Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest.  Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product ......

Global RNAi for Therapeutic Market Status and Outlook 2023-2028

Published: 08-Nov-2023        Price: US 3160 Onwards        Pages: 106

RNAi is a fundamental cellular mechanism for silencing gene expression that can be harnessed for the development of new drugs Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product ......

Global RNAi for Therapeutic Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 24-Oct-2023        Price: US 3380 Onwards        Pages: 104

Market Overview of Global RNAi for Therapeutic market: According to our latest research, the global RNAi for Therapeutic market looks promising in the next 5 years. As of 2022, the global RNAi for Therapeutic market was estimated at USD 260.55 million, and it's anticipated to reach USD 3633.33 million in 2028, with a CAGR of 55.14% during the forecast years. RNA interference (RNAi) is a collection of small RNA directed mechanisms that result in sequence specific inhibition of......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs